STOCK MARKET BSE NSE

ICMR, NCDC to start serosurvey to monitor COVID-19 prevalence at district level

The Indian Council of Medical Research and the National Centre for Disease Control will collaborate with key stakeholders for the survey at 10 health facilities (6 public and 4 private).

Published: 12th May 2020 01:11 AM  |   Last Updated: 12th May 2020 01:11 AM   |  A+A-

Municipal workers wearing protective gear disinfect after cremating the body a man who died due to COVID-19 at a crematorium in Kanyakumari Monday May 11 2020. (Photo | PTI)

By PTI

NEW DELHI: Two government research bodies at the forefront of the fight against the coronavirus are in the process of initiating a population-based serosurvey to monitor the trend in the prevalence of the infection at the district level, the Union Health Ministry said on Monday.

The Indian Council of Medical Research and the National Centre for Disease Control will collaborate with key stakeholders for the survey at 10 health facilities (6 public and 4 private).

A serosurvey involves testing of blood serum of a group of individuals to determine the presence of antibodies against that infection.

The ministry said in a document uploaded on its website that there is a need to establish systematic surveillance for SARS-CoV-2 infection in all districts of the country.

"This surveillance will be in addition to the routine testing as per current testing guidelines," it stated.

The survey will include 200 samples a week and 800 samples per month, it said.

It would test outpatient attendees (non-ILI patients) and pregnant women among the low-risk group, and health care workers among the high-risk population.

At least 100 samples per week and 400 per month of healthcare workers from selected districts would be tested.

The document stated that throat/nasal swabs will be collected for RT-PCR tests and samples would be tested in a one-time pool of 25.

"Results of this sample pooling is only for surveillance purposes. It should not be used for diagnosis of individual patients. In addition to throat/nasal swabs, blood samples should be collected for detecting IgG antibodies for ELISA testing. In subsequent rounds, IgG ELISA based testing of serum samples will replace RTPCR based testing for surveillance purpose," it said.

Data on demographic characteristics will be collected on a specifically designed standard data collection form.

The data will be analyzed locally for action using standard indicator formats.

Indicators for person, place, time and trend analysis will be made.

Data collation and dissemination will take place as decided jointly by ICMR and department of health and family welfare, it said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp